Conflict of interest statement
Dr Brannan receives a 10% portion of royalties for the sale of AridolTM
/ OsmohalerTM that are paid to his prior employer, Royal Prince Alfred
Hospital. He holds a minimum number shares in the manufacturer Pharmaxis
Ltd. In the past has acted as a consultant to Pharmaxis Ltd and the Nth
American distributor of AridolTM, Methapharm Pty Ltd